TOP 10 Countries by Public Health Spending per Capita (2025)
Why public health spending per capita is the cleanest budget signal heading into 2025
Public health spending per capita is one of the best shortcuts for understanding how strongly a country’s health system is backed by pooled public resources. It is not the same as total health spending per person, because total spending also includes private insurance and direct out-of-pocket payments. But for comparing fiscal commitment across countries, government-financed spending per resident is the sharper benchmark.
This 2025-style ranking uses the latest official observations available heading into 2025, mainly from the World Bank and WHO Global Health Expenditure Database, and treats 2024 and late-2023 country observations as the latest fully comparable public-financing snapshot. That matters because there is no closed global 2025 dataset yet for this indicator.
Exact country years can differ slightly in the source series, so the values below are presented as harmonised analytical bands rather than false precision down to the last dollar.
Top 10 countries in the latest public-spending cluster
The ranking is overwhelmingly concentrated in rich OECD systems with broad pooled financing, strong tax or compulsory-insurance capacity and long-standing institutional support for universal or near-universal coverage. The United States sits far above the rest on system scale, while Nordic and Western European countries dominate the next tier.
The United States remains the clear outlier on spending scale. Even though its system relies more on private financing than Nordic models, the public and compulsory component is still larger per resident than anywhere else.
Norway combines high fiscal capacity, strong government financing and a public-first service model. High energy income and broad state capacity make large health budgets easier to sustain.
Germany’s position reflects a large compulsory insurance system with deep employer-employee contribution flows, generous pooled financing and a mature provider base.
Switzerland remains one of the world’s most expensive health systems. Its public-financing share is lower than in Nordic countries, but compulsory coverage and high total spending keep public-backed spending per resident very high.
Luxembourg’s high-income base and broad social protection architecture support one of the highest public health budgets per person in Europe.
Denmark channels a large share of health financing through government budgets and maintains a consistently high public commitment to primary care, hospitals and long-term service quality.
The Dutch system combines mandatory coverage, strong pooling and a high-income tax base. The result is a very large public or compulsory financing envelope per resident.
Sweden stays near the top because government transfers finance the overwhelming majority of healthcare spending and because the country combines high productivity with a broad public-service model.
Austria’s placement reflects stable insurance financing, relatively high per-capita income and a long-standing public role in sustaining access and provider reimbursement.
France rounds out the top cluster with a very large public or compulsory financing base, strong protection from catastrophic costs and a traditionally large state role in healthcare funding.
Table 1. Top 10 countries by public health spending per capita, 2025 snapshot
| Rank | Country | Approx. public spending per capita | Financing profile |
|---|---|---|---|
| 1 | United States | ≈ 9,800 PPP int$ | Very high public + compulsory base within a very expensive mixed system |
| 2 | Norway | ≈ 7,600 PPP int$ | Government-led universal financing |
| 3 | Germany | ≈ 7,100 PPP int$ | Large compulsory social insurance system |
| 4 | Switzerland | ≈ 6,800 PPP int$ | High-cost compulsory coverage with large pooled financing |
| 5 | Luxembourg | ≈ 6,700 PPP int$ | Small high-income social protection model |
| 6 | Denmark | ≈ 6,300 PPP int$ | Tax-funded universal system |
| 7 | Netherlands | ≈ 6,050 PPP int$ | Regulated insurance with strong mandatory pooling |
| 8 | Sweden | ≈ 5,950 PPP int$ | Public-sector dominant financing |
| 9 | Austria | ≈ 5,700 PPP int$ | Mature social insurance financing |
| 10 | France | ≈ 5,450 PPP int$ | Broad compulsory coverage and large state role |
These values are rounded analytical bands built from the latest official public-expenditure observations and OECD financing context. The purpose is to show the leading cluster accurately without pretending that a fully closed official 2025 ranking already exists.
Chart 1. Approximate public health spending per capita in the top 10
Chart fallback: the United States stands well above the rest of the high-spending group, while Norway, Germany, Switzerland and Luxembourg form the next tier. Denmark, the Netherlands, Sweden, Austria and France remain tightly clustered rather than separated by huge gaps.
Values are shown in PPP international dollars per person and are intentionally rounded for comparability.
Methodology
This article is built around the World Bank and WHO Global Health Expenditure Database series for domestic general government health expenditure per capita in PPP terms. The important technical point is that the public World Bank indicator is expressed in current international dollars, not a constant-price series, and the latest official range currently runs through 2024 rather than a closed 2025 year. To produce a “2025 snapshot,” the article harmonises the latest available observations across countries and uses them as the most recent comparable public-financing picture heading into 2025.
OECD Health at a Glance 2025 is used as a second anchor for interpretation because it shows how public funding shares, compulsory insurance structures and overall spending levels differ across rich-country systems. That matters especially for cases like the United States and Switzerland, where high system spending does not map one-to-one onto a pure government-financing model. All country numbers in this page are lightly rounded and grouped into bands to avoid false precision when different countries’ latest observations come from slightly different reporting years.
Limitations matter. Public health expenditure per capita is a strong budget signal, but it does not by itself measure efficiency, equity, waiting times, financial protection quality or health outcomes. Revisions to PPP factors, changes in compulsory insurance classification and national accounting updates can also slightly reorder the top cluster over time.
Insights and conclusions
The first clear insight is concentration. The global leaders are not a random sample of countries but a narrow group of high-income systems with unusually large fiscal space and mature public or compulsory pooling mechanisms. Small Nordic and Western European economies dominate because they combine high labour productivity, broad tax capacity and long-established institutional commitments to universal access.
The second insight is that the United States is an outlier in scale but not a clean template for other countries. It spends far more than any peer system, yet much of the policy debate around American healthcare is about affordability, fragmentation and unequal access. That tells readers something important: the top of a spending ranking is not automatically the top of an outcomes ranking.
The third insight is about divergence. The gap between the top public spenders and low-income systems is still vast. Rich-country public budgets buy dense provider networks, expensive technology, larger workforces and stronger financial protection. In poorer countries, public financing often remains too thin to sustain even a basic package at consistent quality. That gap is why public health spending per capita remains such a powerful shorthand for differences in state capacity and health-system resilience.
What this means for the reader
For an ordinary reader, this ranking is less about abstract fiscal theory and more about what kind of health system people can realistically expect to encounter. Countries high in public spending per capita usually have more room to finance hospitals, primary care, prevention, specialist staffing and protection from catastrophic out-of-pocket costs. They are not perfect systems, but they generally have stronger institutional buffers.
For people comparing relocation options, retirement destinations or long-term family security, public spending per resident is a useful context variable. It does not replace practical questions such as waiting times, insurance rules or provider access, but it tells you whether health is backed by a thin public floor or by a much more substantial pooled-financing base.
FAQ
No. Public spending focuses on what is financed through government budgets and related public schemes. Total spending also includes private insurance and direct household payments.
Because this is a spending ranking, not an efficiency ranking. The United States channels an enormous amount of money through its health system, including a very large public and compulsory component, even though access and affordability remain contested.
PPP adjusts for cross-country price differences. That makes per-person comparisons more meaningful than simply converting spending into U.S. dollars at current exchange rates.
Because the official source series currently runs through 2024 and not every country has the same most recent reported year. A careful ranking should reflect that rather than pretending the global 2025 dataset is already closed.
No. It improves financing capacity and usually strengthens protection, but outcomes also depend on provider organisation, primary care, prevention, equity and cost control.
Yes. That happens when private insurance or household payments make up a larger share of system financing. That is exactly why public spending per capita is useful as a separate metric.
How financing structure and budget priority shape the leaderboard
A country does not enter the global top tier by accident. Very high public health spending per capita usually sits on top of a broader financing model: a large tax base, strong compulsory pooling, stable government revenues and a political choice to keep health near the centre of public spending. That is why the ranking is not just about income levels. It is also about institutions.
OECD evidence helps explain the pattern. On average, public sources financed 72% of healthcare spending across OECD countries in 2023, but the composition of that public funding varies sharply. In Norway and Sweden, government transfers dominate. In Germany and France, compulsory insurance contributions play a much larger role. The headline ranking therefore hides very different financing architectures.
Table 2. Budget priority and financing patterns behind the top-spending group
Health budgets are easiest to sustain when countries combine high fiscal capacity with a strong public or compulsory financing channel. The table below groups the leading systems by how that support is organised.
| Group | Examples | Approx. health share of total government expenditure | How the model works |
|---|---|---|---|
| Government-led champions | Norway, Denmark, Sweden | ≈ 16%–20% | High tax capacity and direct government financing make health a major line item in the public budget. |
| Social insurance heavyweights | Germany, France, Austria, Luxembourg | ≈ 14%–18% | Large compulsory insurance systems pool employer and employee contributions at scale. |
| Mixed high-cost model | United States, Switzerland | ≈ 13%–17% | Public or compulsory financing is very large in absolute terms, but private funding remains unusually important. |
| Regulated mandatory coverage | Netherlands | ≈ 14%–16% | Strong mandatory pooling, regulated insurers and a high-income tax base keep per-capita public funding elevated. |
The purpose here is analytical: different institutional routes can produce high per-capita public financing, but the sustainability and efficiency of those routes are not identical.
Why the global gap remains so wide
The distance between the top public spenders and the rest of the world is still structurally large. Rich-country public budgets are able to support dense provider systems, expensive medicines, sophisticated hospital infrastructure and large professional workforces. Low-income systems, by contrast, often struggle to finance basic service packages at consistent quality, especially when debt pressure or external shocks compress fiscal space.
This is why the global debate about universal health coverage is not only about designing smarter systems. It is also about whether governments can create and protect enough fiscal room for health over many years. Countries that let health budgets lag behind inflation or population needs tend to see shortages accumulate: too few workers, under-supplied clinics, weaker prevention and larger household payment burdens.
A strong ranking position usually reflects three things at once:
- large pooled financing capacity;
- political willingness to keep health high in the budget;
- institutions able to convert money into durable service coverage.
Chart 2. Public health spending per capita, 2000–2024 trend pattern
The long-run picture is not a straight line, but the direction is clear. Top-spending systems expanded public health budgets strongly over the past two decades, OECD averages also rose from a lower level, while low-income countries remained much more constrained. The line chart below is a stylised index built to reflect that official narrative rather than to mimic a single raw database extract.
Chart fallback: the top-spender group shows the steepest long-run rise in public health spending per capita. OECD averages also trend upward, while low-income countries rise much more slowly and remain far below the frontier.
Indexed series, 2000 = 100. The visual is designed to summarise the broad growth gap, not to replace country-by-country database work.
What the public-spending hierarchy says about healthcare systems in 2025
The ranking reinforces one broad reality: very high public health spending per capita is concentrated in a small set of advanced systems that combine strong state capacity with deep pools of compulsory financing. That makes the leaderboard less a story about isolated policy choices and more a story about long-run institutional strength. Countries do not reach this tier simply by announcing universal coverage. They reach it by building a durable fiscal base and protecting health within the budget year after year.
The hierarchy also shows why raw spending numbers must be interpreted carefully. The United States sits first, but that does not automatically make it the most efficient or equitable system. Nordic countries often spend less per person than the United States while relying on more coherent public financing and facing fewer debates about fragmented access. In other words, the ranking tells us who has the biggest pooled public financing envelope, not who has solved every healthcare problem.
At the other end of the spectrum, the contrast with low-income countries remains stark. The World Bank has warned that combined government and donor spending in low-income countries averaged only about $17 per capita in 2024, with real spending stagnating since 2018. That puts the top-spender cluster into perspective: the world is still operating with an enormous gap in public health-system financing capacity.
Policy takeaway
Public health spending per capita is most useful when treated as a starting point for analysis rather than a final verdict on system quality.
- For high-income countries, the key challenge is to keep spending growth aligned with ageing, chronic disease and workforce needs without losing efficiency.
- For insurance-based systems, the priority is maintaining broad pooling and preventing rising household burdens from eroding effective access.
- For middle-income reformers, the lesson is that coverage promises are fragile unless they are matched by stable public financing and stronger budget priority.
- For low-income countries, the ranking highlights how large the financing gap still is between basic service coverage and the spending levels seen in rich-country systems.
- For readers, the smart use of this indicator is comparative: combine it with waiting times, outcomes, private-payment burdens and insurance rules before drawing conclusions.
From a measurement perspective, the safest interpretation is to avoid false precision. PPP revisions, reporting lags and differences between government-only and public-plus-compulsory concepts can all matter. But the broad message is robust: countries near the top have much more room to finance staff, infrastructure, medicines and financial protection than countries far below them.
Primary data sources and technical notes
The figures in this article are harmonised from official international datasets and presented as analytical estimates for publication use. They are rounded for clarity and should not be treated as a substitute for direct country-database extraction.
-
World Bank / WHO Global Health Expenditure DatabaseDomestic general government health expenditure per capita, PPP (current international $), with the public series currently shown for 2000–2024.
https://data.worldbank.org/indicator/SH.XPD.GHED.PP.CD -
World Bank / WHODomestic general government health expenditure as a share of total government expenditure.
https://data.worldbank.org/indicator/SH.XPD.GHED.GE.ZS -
OECD — Health at a Glance 2025Health expenditure per capita and public funding structure across OECD health systems.
https://www.oecd.org/en/publications/health-at-a-glance-2025_8f9e3f98-en/full-report/health-expenditure-per-capita_affe6b0a.html
https://www.oecd.org/en/publications/health-at-a-glance-2025_8f9e3f98-en/full-report/public-funding-of-health-spending_ff3ad2d2.html -
World Bank report note on low-income country financing pressureGlobal context on low-income countries’ health financing constraints and per-capita spending levels.
https://www.worldbank.org/en/news/press-release/2025/11/19/health-financing-challenges-opportunities-changing-aid-landscape-grph
Public rankings work best when triangulated with broader indicators such as total health spending, out-of-pocket burden, service coverage, waiting times and workforce availability.
